After Peter Lim's Entry, TMC Seeks Major Upwave Regionally and at Home
Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
TMC Life Sciences Bhd Group CEO Francis Lim Poon Thoo talks about the reasons behind the resignation of TMC's founder Datuk Dr Colin Lee Soon Soo and the entry of new substantial shareholder, Singaporean billionaire Peter Lim Eng Hock, as well as the implications, outlook for, and expertise he brings to the entity.
He also discusses expectations of a return to profit this year, the 4 income streams of hospital, fertility treatment, wellness programme and stem cell banking services, and which is growing the fastest and the bigest contributor, outlook for earnings and the drivers behind its profitable fertility business.
He also discusses TMC's plans to focus on medical tourism, what's going to drive this surge and what are TMC is doing to drive this.
See omnystudio.com/listener for privacy information.